Trodelvy® (sacituzumab govitecan-hziy)
for Breast Cancer

Trodelvy (sacituzumab govitecan-hziy) is a targeted therapy used to treat locally advanced or metastatic breast cancer. It works by targeting the Trop-2 protein on cancer cells and delivering an anticancer drug directly into them, slowing tumor growth and potentially reducing side effects. Trodelvy may help extend survival and delay cancer progression.

Heart
Other top medicines used to treat Breast Cancer